COMPLETE TEST BANK FOR
PHARMACOTHERAPEUTICS FOR ADVANCED
PRACTICE: A PRACTICAL APPROACH FIFTH,
NORTH AMERICAN EDITION BY VIRGINIA
POOLE ARCANGELO, ANDREW M. PETERSON,
VERONICA WILBUR, DR. TEP M. KANG−
UPDATED CHAPTERS COVERED| FULL GUIDE
WITH VERIFIED QUESTIONS & ACCURATE
SOLUTIONS| 100 % VERIFIED A+GRADE
ASSURED!!!! NEWEST UPDATE!!!!!
,TABLE OF CONTENTS
UNIT 1 PRINCIPLES OF THERAPEUTICS ........................................................................................................ 4
CHAPTER 1 ISSUES FOR THE PRACTITIONER IN DRUG THERAPY .............................................................. 4
CHAPTER 2.PHARMACOKINETIC BASIS OF THERAPEUTICS AND PHARMACODYNAMIC .......................... 6
CHAPTER 3. IMPACT OF DRUG INTERACTIONS AND ADVERSE EVENTS ON THERAPEUTICS .................. 14
CHAPTER 4: PRINCIPLES OF PHARMACOTHERAPY IN PEDIATRICS, PREGNANCY, AND LACTATION ...... 19
CHAPTER 5. PHARMACOTHERAPY PRINCIPLES IN OLDER ADULTS ......................................................... 24
CHAPTER 6. PRINCIPLES OF ANTIMICROBIAL THERAPY .......................................................................... 27
CHAPTER 7. PHARMACOGENOMICS ....................................................................................................... 32
CHAPTER 8. THE ECONOMICS OF PHARMACOTHERAPEUTICS ............................................................... 35
UNIT 2: PRINCIPLES OF PAIN MANAGEMENT............................................................................................ 39
CHAPTER 9 PRINCIPLES OF PHARMACOTHERAPY IN PAIN MANAGEMENT ........................................... 39
CHAPTER 10: PAIN MANAGEMENT IN OPIOID USE DISORDER (OUD) PATIENTS ................................... 44
CHAPTER 11: CANNABIS AND PAIN MANAGEMENT ............................................................................... 66
UNIT 3: PHARMACOTHERAPY FOR SKIN DISORDERS ................................................................................ 78
CHAPTER 12. CONTACT DERMATITIS ...................................................................................................... 78
CHAPTER 13: BACTERIAL, FUNGAL, AND VIRAL INFECTIONS OF THE SKIN............................................. 82
CHAPTER 14. PSORIASIS .......................................................................................................................... 93
CHAPTER 15. ACNE VULGARIS AND ROSACEA ........................................................................................ 95
UNIT 4: PHARMACOTHERAPY FOR EYE AND EAR DISORDERS.................................................................. 96
CHAPTER 16 OPHTHALMIC DISORDERS .................................................................................................. 96
CHAPTER 17. OTITIS MEDIA AND OTITIS EXTERNA ............................................................................... 101
,UNIT 5: PHARMACOTHERAPY FOR CARDIOVASCULAR DISORDERS ....................................................... 105
CHAPTER 18. HYPERTENSION ............................................................................................................... 105
CHAPTER 19. HYPERLIPIDEMIA ............................................................................................................. 109
CHAPTER 20: CHRONIC STABLE ANGINA AND MYOCARDIAL INFARCTION .......................................... 113
CHAPTER 21. HEART FAILURE ............................................................................................................... 155
CHAPTER 22: ARRHYTHMIAS ................................................................................................................ 159
UNIT 6: PHARMACOTHERAPY FOR RESPIRATORY DISORDERS............................................................... 167
CHAPTER 23: RESPIRATORY INFECTIONS .............................................................................................. 167
CHAPTER 24: ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE ...................................... 176
UNIT 7: PHARMACOTHERAPY FOR GASTROINTESTINAL DISORDERS..................................................... 181
CHAPTER 25: GASTRIC, FUNCTIONAL AND INFLAMMATORY BOWEL DISORDERS .............................. 181
CHAPTER 26. GASTROESOPHAGEAL REFLUX DISEASE AND PEPTIC ULCER DISEASE ............................ 201
CHAPTER 27: LIVER DISEASES ............................................................................................................... 204
UNIT 8: PHARMACOTHERAPY FOR GENITOURINARY TRACT DISORDERS .............................................. 223
CHAPTER 28. URINARY TRACT INFECTIONS .......................................................................................... 223
CHAPTER 29. PROSTATIC DISORDERS AND ERECTILE DYSFUNCTION ................................................... 226
CHAPTER 30. OVERACTIVE BLADDER .................................................................................................... 250
CHAPTER 31. SEXUALLY TRANSMITTED INFECTIONS ............................................................................ 252
UNIT 9: PHARMACOLOGY FOR MUSCULOSKELETAL DISORDERS ........................................................... 255
CHAPTER 32. OSTEOARTHRITIS AND GOUT .......................................................................................... 255
CHAPTER 33. OSTEOPOROSIS ............................................................................................................... 261
CHAPTER 34. RHEUMATOID ARTHRITIS ................................................................................................ 264
UNIT 10: PHARMACOTHERAPY FOR NEUROLOGICAL DISORDERS ......................................................... 281
CHAPTER 35. HEADACHES ..................................................................................................................... 281
CHAPTER 36. SEIZURE DISORDERS ........................................................................................................ 285
CHAPTER 37. ALZHEIMER’S DISEASE ..................................................................................................... 289
CHAPTER 38. PARKINSON DISEASE ....................................................................................................... 291
UNIT 11: PHARMACOTHERAPY FOR MENTAL HEALTH DISORDERS ....................................................... 298
CHAPTER 39: MAJOR DEPRESSIVE DISORDER AND BIPOLAR DISORDERS ............................................ 298
CHAPTER 40. ANXIETY DISORDERS ....................................................................................................... 328
CHAPTER 41. SLEEP DISORDERS ............................................................................................................ 367
CHAPTER 42. ATTENTION DEFICIT HYPERACTIVITY DISORDER ............................................................. 368
CHAPTER 43: SUBSTANCE USE DISORDERS........................................................................................... 370
, UNIT 12: PHARMACOTHERAPY FOR ENDOCRINE DISORDERS ................................................................ 378
CHAPTER 44. DIABETES MELLITUS ........................................................................................................ 378
CHAPTER 45: THYROID AND PARATHYROID DISORDERS ...................................................................... 386
UNIT 13: PHARMACOTHERAPY FOR IMMUNOLOGY .............................................................................. 405
CHAPTER 46. ALLERGIES AND ALLERGIC REACTIONS............................................................................ 405
CHAPTER 47. HUMAN IMMUNODEFICIENCY VIRUS ............................................................................. 409
CHAPTER 48: ORGAN TRANSPLANTATION............................................................................................ 412
UNIT 14: PHARMACOTHERAPY FOR THROMBOEMBOLIC DISORDERS .................................................. 422
CHAPTER 49: PHARMACOTHERAPY FOR SELECT THROMBOEMBOLIC DISORDERS.............................. 422
CHAPTER 50. ANEMIAS ......................................................................................................................... 429
UNIT 15: PHARMACOTHERAPY FOR HEALTH PROMOTION .................................................................... 433
CHAPTER 51. IMMUNIZATIONS ............................................................................................................ 433
CHAPTER 52. SMOKING CESSATION ..................................................................................................... 437
CHAPTER 53. WEIGHT LOSS .................................................................................................................. 440
UNIT 16: PHARMACOTHERAPY FOR WOMEN’S HEALTH ........................................................................ 443
CHAPTER 54. CONTRACEPTION............................................................................................................. 443
CHAPTER 55. MENOPAUSE ................................................................................................................... 446
CHAPTER 56. VAGINITIS ........................................................................................................................ 458
UNIT 1 PRINCIPLES OF THERAPEUTICS
CHAPTER 1 ISSUES FOR THE PRACTITIONER IN DRUG THERAPY
MULTIPLE CHOICE
1. NURSE PRACTITIONER PRESCRIPTIVE AUTHORITY IS REGULATED BY:
A. THE NATIONAL COUNCIL OF STATE BOARDS OF NURSING
B. THE U.S. DRUG ENFORCEMENT ADMINISTRATION
C. THE STATE BOARD OF NURSING FOR EACH STATE
D. THE STATE BOARD OF PHARMACY
ACCURATE ANS: C PTS: 1
PHARMACOTHERAPEUTICS FOR ADVANCED
PRACTICE: A PRACTICAL APPROACH FIFTH,
NORTH AMERICAN EDITION BY VIRGINIA
POOLE ARCANGELO, ANDREW M. PETERSON,
VERONICA WILBUR, DR. TEP M. KANG−
UPDATED CHAPTERS COVERED| FULL GUIDE
WITH VERIFIED QUESTIONS & ACCURATE
SOLUTIONS| 100 % VERIFIED A+GRADE
ASSURED!!!! NEWEST UPDATE!!!!!
,TABLE OF CONTENTS
UNIT 1 PRINCIPLES OF THERAPEUTICS ........................................................................................................ 4
CHAPTER 1 ISSUES FOR THE PRACTITIONER IN DRUG THERAPY .............................................................. 4
CHAPTER 2.PHARMACOKINETIC BASIS OF THERAPEUTICS AND PHARMACODYNAMIC .......................... 6
CHAPTER 3. IMPACT OF DRUG INTERACTIONS AND ADVERSE EVENTS ON THERAPEUTICS .................. 14
CHAPTER 4: PRINCIPLES OF PHARMACOTHERAPY IN PEDIATRICS, PREGNANCY, AND LACTATION ...... 19
CHAPTER 5. PHARMACOTHERAPY PRINCIPLES IN OLDER ADULTS ......................................................... 24
CHAPTER 6. PRINCIPLES OF ANTIMICROBIAL THERAPY .......................................................................... 27
CHAPTER 7. PHARMACOGENOMICS ....................................................................................................... 32
CHAPTER 8. THE ECONOMICS OF PHARMACOTHERAPEUTICS ............................................................... 35
UNIT 2: PRINCIPLES OF PAIN MANAGEMENT............................................................................................ 39
CHAPTER 9 PRINCIPLES OF PHARMACOTHERAPY IN PAIN MANAGEMENT ........................................... 39
CHAPTER 10: PAIN MANAGEMENT IN OPIOID USE DISORDER (OUD) PATIENTS ................................... 44
CHAPTER 11: CANNABIS AND PAIN MANAGEMENT ............................................................................... 66
UNIT 3: PHARMACOTHERAPY FOR SKIN DISORDERS ................................................................................ 78
CHAPTER 12. CONTACT DERMATITIS ...................................................................................................... 78
CHAPTER 13: BACTERIAL, FUNGAL, AND VIRAL INFECTIONS OF THE SKIN............................................. 82
CHAPTER 14. PSORIASIS .......................................................................................................................... 93
CHAPTER 15. ACNE VULGARIS AND ROSACEA ........................................................................................ 95
UNIT 4: PHARMACOTHERAPY FOR EYE AND EAR DISORDERS.................................................................. 96
CHAPTER 16 OPHTHALMIC DISORDERS .................................................................................................. 96
CHAPTER 17. OTITIS MEDIA AND OTITIS EXTERNA ............................................................................... 101
,UNIT 5: PHARMACOTHERAPY FOR CARDIOVASCULAR DISORDERS ....................................................... 105
CHAPTER 18. HYPERTENSION ............................................................................................................... 105
CHAPTER 19. HYPERLIPIDEMIA ............................................................................................................. 109
CHAPTER 20: CHRONIC STABLE ANGINA AND MYOCARDIAL INFARCTION .......................................... 113
CHAPTER 21. HEART FAILURE ............................................................................................................... 155
CHAPTER 22: ARRHYTHMIAS ................................................................................................................ 159
UNIT 6: PHARMACOTHERAPY FOR RESPIRATORY DISORDERS............................................................... 167
CHAPTER 23: RESPIRATORY INFECTIONS .............................................................................................. 167
CHAPTER 24: ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE ...................................... 176
UNIT 7: PHARMACOTHERAPY FOR GASTROINTESTINAL DISORDERS..................................................... 181
CHAPTER 25: GASTRIC, FUNCTIONAL AND INFLAMMATORY BOWEL DISORDERS .............................. 181
CHAPTER 26. GASTROESOPHAGEAL REFLUX DISEASE AND PEPTIC ULCER DISEASE ............................ 201
CHAPTER 27: LIVER DISEASES ............................................................................................................... 204
UNIT 8: PHARMACOTHERAPY FOR GENITOURINARY TRACT DISORDERS .............................................. 223
CHAPTER 28. URINARY TRACT INFECTIONS .......................................................................................... 223
CHAPTER 29. PROSTATIC DISORDERS AND ERECTILE DYSFUNCTION ................................................... 226
CHAPTER 30. OVERACTIVE BLADDER .................................................................................................... 250
CHAPTER 31. SEXUALLY TRANSMITTED INFECTIONS ............................................................................ 252
UNIT 9: PHARMACOLOGY FOR MUSCULOSKELETAL DISORDERS ........................................................... 255
CHAPTER 32. OSTEOARTHRITIS AND GOUT .......................................................................................... 255
CHAPTER 33. OSTEOPOROSIS ............................................................................................................... 261
CHAPTER 34. RHEUMATOID ARTHRITIS ................................................................................................ 264
UNIT 10: PHARMACOTHERAPY FOR NEUROLOGICAL DISORDERS ......................................................... 281
CHAPTER 35. HEADACHES ..................................................................................................................... 281
CHAPTER 36. SEIZURE DISORDERS ........................................................................................................ 285
CHAPTER 37. ALZHEIMER’S DISEASE ..................................................................................................... 289
CHAPTER 38. PARKINSON DISEASE ....................................................................................................... 291
UNIT 11: PHARMACOTHERAPY FOR MENTAL HEALTH DISORDERS ....................................................... 298
CHAPTER 39: MAJOR DEPRESSIVE DISORDER AND BIPOLAR DISORDERS ............................................ 298
CHAPTER 40. ANXIETY DISORDERS ....................................................................................................... 328
CHAPTER 41. SLEEP DISORDERS ............................................................................................................ 367
CHAPTER 42. ATTENTION DEFICIT HYPERACTIVITY DISORDER ............................................................. 368
CHAPTER 43: SUBSTANCE USE DISORDERS........................................................................................... 370
, UNIT 12: PHARMACOTHERAPY FOR ENDOCRINE DISORDERS ................................................................ 378
CHAPTER 44. DIABETES MELLITUS ........................................................................................................ 378
CHAPTER 45: THYROID AND PARATHYROID DISORDERS ...................................................................... 386
UNIT 13: PHARMACOTHERAPY FOR IMMUNOLOGY .............................................................................. 405
CHAPTER 46. ALLERGIES AND ALLERGIC REACTIONS............................................................................ 405
CHAPTER 47. HUMAN IMMUNODEFICIENCY VIRUS ............................................................................. 409
CHAPTER 48: ORGAN TRANSPLANTATION............................................................................................ 412
UNIT 14: PHARMACOTHERAPY FOR THROMBOEMBOLIC DISORDERS .................................................. 422
CHAPTER 49: PHARMACOTHERAPY FOR SELECT THROMBOEMBOLIC DISORDERS.............................. 422
CHAPTER 50. ANEMIAS ......................................................................................................................... 429
UNIT 15: PHARMACOTHERAPY FOR HEALTH PROMOTION .................................................................... 433
CHAPTER 51. IMMUNIZATIONS ............................................................................................................ 433
CHAPTER 52. SMOKING CESSATION ..................................................................................................... 437
CHAPTER 53. WEIGHT LOSS .................................................................................................................. 440
UNIT 16: PHARMACOTHERAPY FOR WOMEN’S HEALTH ........................................................................ 443
CHAPTER 54. CONTRACEPTION............................................................................................................. 443
CHAPTER 55. MENOPAUSE ................................................................................................................... 446
CHAPTER 56. VAGINITIS ........................................................................................................................ 458
UNIT 1 PRINCIPLES OF THERAPEUTICS
CHAPTER 1 ISSUES FOR THE PRACTITIONER IN DRUG THERAPY
MULTIPLE CHOICE
1. NURSE PRACTITIONER PRESCRIPTIVE AUTHORITY IS REGULATED BY:
A. THE NATIONAL COUNCIL OF STATE BOARDS OF NURSING
B. THE U.S. DRUG ENFORCEMENT ADMINISTRATION
C. THE STATE BOARD OF NURSING FOR EACH STATE
D. THE STATE BOARD OF PHARMACY
ACCURATE ANS: C PTS: 1
